Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Earnings numbers..
View:
Post by Ricksterh1 on Nov 02, 2016 2:17pm

Earnings numbers..

will show where the company is headed. If weaker than expected, the stock will probably drop based upon the unknown of when the numbers will stabilize. If they surprise on the upside, it will be another positive for the company. Then, it will be a matter of what they will do from there. Either they will have to work at stabilizing the numbers, if weaker, or figuring out how to move ahead with available cash for the biggest bang for the buck. A share buyback is a possibility. If the stock drops further they may have to delist from the Nasdaq (I don't see that as a negative in the present environment), lots they can do. Bring the company back to just a Canadian listing and start reporting in Cdn. $$. Retrench and move ahead. Course this won't happen as they will try and keep the US listing but it really does them more harm than good right now. Tighten the float perhaps? I would rather see that than debt paydown but debt is what the analysts are focused on. If the stock drops much more, it is a sitting duck for a takeover, management buyout etc. Pretty hard for he analysts with $3 and $4 target prices to suddenly reverse sentiment and say the company is worth more if management decides to buy it out. There is a good reason we need a higher stock price than what the market is giving us. Hey, it is possible now that MT is out that he organizes a group to take the company private!!  Market cap is only $230 million!!
Comment by Kazinsky on Nov 02, 2016 2:41pm
Doubtful.  The very fact that the CEO had his stock margined says you are out of touch if you think he wants to take the company private.   Further, the fact that he didn't cover his margin call on the recent stock sale says he has some liquidity problems ... Or else he doesn't believe in the company's future prospects ... Or both ...Probably both.   Kupinsky,  the ...more  
Comment by Nossy45 on Nov 02, 2016 2:43pm
Yes, I think it is obvious that MT probably had financial habits similair to CXR's. He probably took on some personal debt
Comment by borrowedlife on Nov 02, 2016 2:51pm
Financial habits ? Buggers are $5 obviously that sent him into personal debt...how many burgers does one need 
Comment by Nossy45 on Nov 02, 2016 3:44pm
Hahaha .... a lot of wealthy people take our large debts against there homes, mortgages, cars, watches, stocks
Comment by Lumberfeverlong on Nov 02, 2016 5:56pm
I've said this countless times on this board.  MT could not cover the margin call while the company was in a blackout. Doing so would have amounted to insider trading because it would have involved making an investment decision on the shares of the company.    
Comment by smallshort on Nov 02, 2016 4:45pm
Are you people rookie investors or you just pretend to be?  The market cap is irrelevant at this point, it's the debt that's the anchor and choke point on this company.  Servicing the interest is the biggest issue. That plus the $200M holdback they need to pay to Cinven.  And to make matters worst, don't they have more holdbacks as part of the June deal for the four ...more  
Comment by ryehigh2014 on Nov 02, 2016 5:09pm
Dude they have sufficient C/F to meet the interest expense and some! and as a company they better be buying drugs with performance thresholds (contingent payouts). The whole point of that is to pay less for the portfolio. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse